Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics

Area of Science:

• Oncology
• Cancer Biology
• Stem Cell Research

Background:

• Cancer stem cells (CSCs) are crucial for tumor propagation, resistance to therapy, and relapse.
• CSCs can arise from normal cells or through dedifferentiation of non-stem cancer cells.
• Tumor microenvironment and epigenetic changes drive CSC formation and cancer cell plasticity.

Purpose of the Study:

• To elucidate the role of cancer cell origin and CSC plasticity in solid tumor initiation and maintenance.
• To discuss signaling pathways and epigenetic mechanisms involved in CSC formation.
• To review strategies for targeting CSCs and cancer cell plasticity.

Main Methods:

• Review of current literature on cancer stem cells.
• Analysis of signaling pathways and epigenetic mechanisms.
• Synthesis of therapeutic strategies targeting CSCs.

Main Results:

• CSCs possess inherent resistance to conventional treatments, contributing to tumor recurrence.
• Cancer cell plasticity, influenced by the microenvironment and epigenetics, is vital for tumor heterogeneity.
• Specific signaling pathways and epigenetic alterations are critical for CSC maintenance.

Conclusions:

• Targeting CSCs and their plasticity is essential for effective cancer therapy.
• Understanding the origin and maintenance of CSCs offers new therapeutic avenues.
• Epigenetic reprogramming and microenvironmental factors are key regulators of CSCs.